ABBV-547 Clinical Trials (2026): 1 Studies for Healthy Volunteer
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
1 ABBV-547 clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 1 indication (including Healthy Volunteer) and 87 total planned enrollment. 1 ABBV-547 clinical trial is actively recruiting at 2 U.S. sites across 2 states. Most recent activity: NCT07232004 (Sep 2027).
Where to Participate: All ABBV-547 Trial Sites in the U.S. (2 sites across 2 states)
Every actively recruiting ABBV-547trial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.
| State | Facility | City | Trial | Map |
|---|---|---|---|---|
| CA | CenExel ACT- Anaheim Clinical Trials /ID# 279612 | Anaheim92801 | NCT07232004 | Map |
| IL | Acpru /Id# 278638 | Grayslake60030 | NCT07232004 | Map |
ABBV-547 clinical trials at a glance: phase × recruitment status
| Phase | recruiting | Total |
|---|---|---|
| P1 | 1 | 1 |
Recruiting ABBV-547 clinical trials (1)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT07232004 | A Study to Evaluate How the Study Drug Moves Through the Body, Adverse Events, and How the Body Tolerates ABBV-547 Injections | P1 | Healthy Volunteer | 87 | Nov 2025 |
All ABBV-547 trials (1)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT07232004 | A Study to Evaluate How the Study Drug Moves Through the Body, Adverse Events, and How the Body Tolerates ABBV-547 Injections | P1 | recruiting | 87 | AbbVie | Nov 2025 |
ABBV-547 clinical trials: frequently asked questions
- How many ABBV-547 clinical trials are there?
- 1 ABBV-547 clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 1 is actively recruiting participants.
- Are ABBV-547 clinical trials recruiting in 2026?
- Yes — 1 ABBV-547 trial is actively recruiting in 2026, with 2 U.S. sites across 2 states. See the recruiting trials and the per-state site list further down this page.
- What conditions is ABBV-547 being studied for?
- ABBV-547 is being studied for Healthy Volunteer. The trials are grouped by indication on this page.
- What phase is ABBV-547 in?
- ABBV-547 clinical trials span 1 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
- Who sponsors ABBV-547 clinical trials?
- The lead sponsor across the most ABBV-547 trials is AbbVie. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming ABBV-547as an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: